Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
BMC Medical Research Methodology
Published in: BMC Medical Research Methodology 1/2009

Open Access 01-12-2009 | Research article

Interim data monitoring to enroll higher-risk participants in HIV prevention trials

Authors: Vera Halpern, Orikomaba Obunge, Folasade Ogunsola, Sakiru Otusanya, John Umo-Otong, Chin-Hua Wang, Neha Mehta

Published in: BMC Medical Research Methodology | Issue 1/2009

Login to get access

Abstract

Background

Lower-than-expected incidence of HIV undermines sample size calculations and compromises the power of a HIV prevention trial. We evaluated the effectiveness of interim monitoring of HIV infection rates and on-going modification of recruitment strategies to enroll women at higher risk of HIV in the Cellulose Sulfate Phase III study in Nigeria.

Methods

We analyzed prevalence and incidence of HIV and other sexually transmitted infections, demographic and sexual behavior characteristics aggregated over the treatment groups on a quarterly basis. The site investigators were advised on their recruitment strategies based on the findings of the interim analyses.

Results

A total of 3619 women were screened and 1644 enrolled at the Ikeja and Apapa clinics in Lagos, and at the Central and Peripheral clinics in Port Harcourt. Twelve months after study initiation, the overall incidence of HIV was less than one-third of the pre-study assumption, with rates of HIV that varied substantially between clinics. Due to the low prevalence and incidence rates of HIV, it was decided to close the Ikeja clinic in Lagos and to find new catchment areas in Port Harcourt. This strategy was associated with an almost two-fold increase in observed HIV incidence during the second year of the study.

Conclusion

Given the difficulties in estimating HIV incidence, a close monitoring of HIV prevalence and incidence rates during a trial is warranted. The on-going modification of recruitment strategies based on the regular analysis of HIV rates appeared to be an efficient method for targeting populations at greatest risk of HIV infection and increasing study power in the Nigeria trial.

Trial Registration

The trial was registered with the ClinicalTrials.gov registry under #NCT00120770 http://​clinicaltrials.​gov/​ct2/​show/​NCT00120770
Appendix
Available only for authorised users
Literature
1.
Skoler S, Peterson L, Cates W: Our current microbicide trials: lessons learned and to be learned. The Microbicide Quarterly. 2006, 4-
2.
Peterson L, Nanda K, Opoku BK, Ampofo WK, Owusu-Amoako M, Boakye AY, Rountree W, Troxler A, Dominik R, Roddy R, Dorflinger L: SAVVY (C31G) gel for prevention of HIV infection in women: a Phase 3, double-blind, randomized, placebo-controlled trial in Ghana. PLoS ONE. 2007, 2: e1312-10.1371/journal.pone.0001312.CrossRefPubMedPubMedCentral
3.
Feldblum PJ, Adeiga A, Bakare R, Wevill S, Lendvay A, Obadaki F, Olayemi MO, Wang L, Nanda K, Rountree W: SAVVY Vaginal Gel (C31G) for Prevention of HIV Infection: A Randomized Controlled Trial in Nigeria. PLoS ONE. 2008, 3: e1474-10.1371/journal.pone.0001474.CrossRefPubMedPubMedCentral
4.
5.
National Population Commission (Nigeria) and ORC Macro: Nigeria Demographic and Health Survey. 2003, Calverton, Maryland
6.
The Federal Ministry of Health: A Technical Report on the 2001 National HIV/Syphilis Sentinal Survey among Pregnant Women Attending Antenatal Clinics in Nigeria. 2001
7.
Roddy RE, Zekeng L, Ryan KA, Tamoufe U, Weir SS, Wong EL: A controlled trial of nonoxynol 9 film to reduce male-to-female transmission of sexually transmitted diseases. N Engl J Med. 1998, 339: 504-10. 10.1056/NEJM199808203390803.CrossRefPubMed
8.
Halpern V, Ogunsola F, Obunge O, Wang C, Onyejepu N, Oduyebo O, Taylor D, McNeil L, Mehta N, Umo-Otong J, Otusanya S, Crucitti T, Abdellati S: Effectiveness of Cellulose Sulfate Vaginal Gel for the Prevention of HIV Infection: Results of a Phase III Trial in Nigeria. PLoS ONE. 2008, 3: e3784-10.1371/journal.pone.0003784.CrossRefPubMedPubMedCentral
9.
Van Damme L, Govinden R, Guedou F, Becker ML, Pradeep B, Alary M, Ramjee G, Murphy S, Deese J, Crucitti T, Taylor D: Phase III trial of 6% cellulose sulfate (CS) gel for the prevention of HIV transmission. IAS 2007, Sydney, Australia. 2007
10.
Ramjee G, Kapiga S, Weiss S, Peterson L, Leburg C, Kelly C, Masse B: The value of site preparedness studies for future implementation of phase 2/IIb/III HIV prevention trials: experience from the HPTN 055 study. J Acquir Immune Defic Syndr. 2008, 47: 93-100. 10.1097/QAI.0b013e31815c71f7.CrossRefPubMed
11.
Kapina M, Reid C, Roman K, Cyrus-Cameron E, Kwiecien A, Weiss S, Vermund S: HIV Incidence Rates and Risk Factors for Urban Women in Zambia: Preparing for a Microbicide Clinical Trial. Sex Transm Dis. 2009
12.
Parekh BS, Kennedy MS, Dobbs T, Pau CP, Byers R, Green T, Hu DJ, Vanichseni S, Young NL, Choopanya K, Mastro TD, McDougal JS: Quantitative detection of increasing HIV type 1 antibodies after seroconversion: a simple assay for detecting recent HIV infection and estimating incidence. AIDS Res Hum Retroviruses. 2002, 18: 295-307. 10.1089/088922202753472874.CrossRefPubMed
13.
UNAIDS Reference Group for Estimates, Modelling and Projections: Statement on the use of the BED-assay for the estimation of HIV-1 incidence for surveillance or epidemic monitoring. 2005, Geneva: UNAIDS
14.
Peterson L, Taylor D, Roddy R, Belai G, Phillips P, Nanda K, Grant R, Clarke EE, Doh AS, Ridzon R, Jaffe HS, Cates W: Tenofovir disoproxil fumarate for prevention of HIV infection in women: a phase 2, double-blind, randomized, placebo-controlled trial. PLoS Clin Trials. 2007, 2: e27-10.1371/journal.pctr.0020027.CrossRefPubMedPubMedCentral
15.
Padian NS, Straten van der A, Ramjee G, Chipato T, de Bruyn G, Blanchard K, Shiboski S, Montgomery ET, Fancher H, Cheng H, Rosenblum M, Laan van der M, Jewell N, McIntyre J: Diaphragm and lubricant gel for prevention of HIV acquisition in southern African women: a randomised controlled trial. Lancet. 2007, 370: 251-61. 10.1016/S0140-6736(07)60950-7.CrossRefPubMedPubMedCentral
16.
Metadata
Title
Interim data monitoring to enroll higher-risk participants in HIV prevention trials
Authors
Vera Halpern
Orikomaba Obunge
Folasade Ogunsola
Sakiru Otusanya
John Umo-Otong
Chin-Hua Wang
Neha Mehta
Publication date
01-12-2009
Publisher
BioMed Central
Published in
BMC Medical Research Methodology / Issue 1/2009
Electronic ISSN: 1471-2288
DOI
https://doi.org/10.1186/1471-2288-9-44

Other articles of this Issue 1/2009

BMC Medical Research Methodology 1/2009 Go to the issue

Research article

Analysis of neonatal clinical trials with twin births

Research article

Effect of questionnaire structure on recall of drug utilization in a population of university students

Research article

A multivariate hierarchical Bayesian approach to measuring agreement in repeated measurement method comparison studies

Research article

Combining estimates of interest in prognostic modelling studies after multiple imputation: current practice and guidelines

Research article

Multivariate random effects meta-analysis of diagnostic tests with multiple thresholds

Research article

Interviewee Transcript Review: assessing the impact on qualitative research